Related Experiment Video
Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Clinical Manifestations
Benoît Jobin1,2,3, Johannes Frasnelli1,2, Natalie A Phillips4
1Research Center of the Hôpital du Sacré-Cœur de Montréal, Montréal, QC, Canada.
Olfactory identification ability predicts episodic memory decline in individuals with mild cognitive impairment (MCI) and subjective cognitive decline (SCD). This suggests smell tests could be early screening tools for Alzheimer's disease (AD) risk.
Area of Science:
- Neurology
- Cognitive Science
- Gerontology
Background:
- Olfactory identification deficits are early indicators in Alzheimer's disease (AD) and mild cognitive impairment (MCI).
- Previous research links olfactory identification to episodic memory in cognitively healthy older adults.
- Olfactory identification may serve as a marker for episodic memory decline in individuals at risk for AD.
Purpose of the Study:
- To assess the predictive value of olfactory identification for episodic memory in individuals with MCI and subjective cognitive decline (SCD).
- To explore the utility of olfactory identification in differentiating between MCI and SCD groups.
Main Methods:
- The University of Pennsylvania Smell Identification Test (UPSIT) assessed olfactory function in 93 participants (48 SCD, 45 MCI).
- Episodic memory was measured using Rey Auditory Verbal Learning Test (RAVLT) recall scores.
- LASSO regression and Linear Discriminant Analysis (LDA) were used for predictive modeling and group classification.
Main Results:
- UPSIT scores significantly correlated with both immediate and delayed RAVLT recall.
- Including UPSIT scores in predictive models improved the explained variance for episodic memory.
- The MCI group had significantly lower UPSIT scores than the SCD group, with LDA achieving moderate accuracy (69%) in group discrimination.
Conclusions:
- Olfactory identification enhances episodic memory prediction in individuals with SCD or MCI.
- Smell identification tests show potential as screening tools for cognitive decline associated with AD.
- Further research is needed to understand the mechanisms of olfactory impairment in AD, as it is not specific to the disease.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Endocarditis II: Clinical Features of Infective Endocarditis
Heart Failure III: Clinical Manifestations
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Hypertension III: Clinical Manifestations and Diagnostic Studies

